Pharmacology for Heart Failure

Author(s): Cynthia Webner

Contact Hours 2.50

CERP A 2.50

Pharmacology Hours 2.50

Expires Dec 31, 2025

Topics: Cardiovascular, Pharmacology

Population: Adult

Role: APRN

Fees
Member: Free
NonMember: $25.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Approximately 6.8 million Americans have heart failure with nearly 1 million new cases identified annually. Heart failure is the primary reason for hospital admission in older adults. In these chronically critically ill patients, pharmacology decision-making is complex and challenging. You will learn initiation, up-titration, monitoring, and contraindications for evidence-based medications for both HFrEF and HFpEF. This session integrates the newest guidelines and expert consensus recommendations from the American College of Cardiology and the American Heart Association. APRNs increase their clinical decision-making expertise using complex and challenging case studies.

Objectives

  • Review safe prescribing and monitoring for medications used in heart failure with reduced left ventricular ejection fraction.
  • Discuss strategies for diuretic use to achieve and maintain euvolemia.
  • Contrast pharmacological therapy for heart failure with reduced ejection with therapy for preserved ejection fraction.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.